JW Pharmaceutical Competitors and Similar CompaniesClear all
JW Pharmaceutical's competitors and similar companies include Calithera Biosciences, MEI Pharma, Virometix and AltruBio.
 JW Pharmaceutical JW Pharmaceutical (formerly Choongwae Pharma) is a pharmaceutical company that develops antibiotics, intravenous solutions, and anti-cancer treatments. |  Calithera Biosciences Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. |  MEI Pharma MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer. |  Virometix Virometix is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. |  AltruBio AltruBio (formerly AbGenomics) is a biopharmaceutical company focused on developing antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases. | |
Founding Date | Founding Date 1945 | Founding Date 2010 | Founding Date 2000 | Founding Date 2009 | Founding Date 2006 |
Type | Type Public | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations South San Francisco, US HQ | Locations San Diego, US HQ | Locations Schlieren, CH HQ | Locations Redwood City, US HQ Amsterdam, NL |
Employees | Employees N/A | Employees 798% increase | Employees 4025% increase | Employees 18 | Employees 296% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 29.2 k | Valuation ($) 21.1 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ₩775.3b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $65.3m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ₩61.5b (FY, 2025) | Net income ($39.7m) (FY, 2022) | Net income $17.8m (FY, 2024) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 8m (almost 6 years ago) | Latest funding round $ 13.2m (almost 12 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 105m | Total funding raised $ 1.1m | Total funding raised $ 18.5m | Total funding raised $ 39.7m |
For sources of this data, please see the company profile
View Company Profiles
Calithera Biosciences
HQ
South San Francisco, US
Employees
79↑ 8% increase
Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
View companyMEI Pharma
HQ
San Diego, US
Employees
40↑ 25% increase
MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.
View companyVirometix
HQ
Schlieren, CH
Employees
18
Virometix is a biotechnology company that develops vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.
View companyAltruBio
HQ
Redwood City, US
Employees
29↓ 6% decrease
AltruBio (formerly AbGenomics) is a biopharmaceutical company focused on developing antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases.
View company